{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:45:23Z","timestamp":1789595123233,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd005262.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000}}],"reference-count":118,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005262.pub4","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T11:32:48Z","timestamp":1602847968000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pentoxifylline for intermittent claudication"],"prefix":"10.1002","volume":"2020","author":[{"given":"Cathryn","family":"Broderick","sequence":"additional","affiliation":[{"name":"Usher Institute; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Forster","sequence":"additional","affiliation":[{"name":"Usher Institute; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abdel-Hadi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Diseases; Herz-Kreislauf-Zentrum Rotenburg; Rotenburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Salhiyyah","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Middle East University; Amman Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD005262.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0002-8703(82)90401-X","article-title":"Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin","volume":"103","author":"Accetto","year":"1982","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0002|cit2","first-page":"39","article-title":"Intermittent claudication in diabetics: treatment with exercise and pentoxifylline - a 6-month, controlled, randomized trial","volume":"53 Suppl 1","author":"Belcaro","year":"2002","journal-title":"Angiology"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0003|cit3","first-page":"5","article-title":"Efficacy and tolerance of Ginkgo biloba extract compared to that of pentoxifylline in the treatment of patients suffering from peripheral chronic arterial occlusive disease","volume":"20","author":"Bohmer","year":"1988","journal-title":"Hers Kreislauf"},{"issue":"9","key":"10.1002\/14651858.CD005262.pub4-BIB0004|cit4","first-page":"557","article-title":"Double-blind study of pentoxifylline against placebo in patients with intermittent claudication","volume":"1","author":"Bollinger","year":"1977","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000331970205300101","article-title":"Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial","volume":"53 Suppl 1","author":"Cesarone","year":"2002","journal-title":"Angiology"},{"issue":"7","key":"10.1002\/14651858.CD005262.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/000331979404500708","article-title":"Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs","volume":"45","author":"Chacon-Quevedo","year":"1994","journal-title":"Angiology"},{"issue":"3","key":"10.1002\/14651858.CD005262.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/000331979704800306","article-title":"A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly","volume":"48","author":"Ciocon","year":"1997","journal-title":"Angiology"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1358863X07084910","article-title":"A randomized trial of iloprost in patients with intermittent claudication","volume":"13","author":"Creager","year":"2008","journal-title":"Vascular Medicine"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0009|cit9","first-page":"1","article-title":"Cilostozol or pentoxifylline for claudication","volume":"98 Suppl 1","author":"Dawson","year":"1998","journal-title":"Circulation"},{"issue":"7","key":"10.1002\/14651858.CD005262.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005262.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/000331970205300503","article-title":"Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication","volume":"53","author":"Dawson","year":"2002","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0012|cit12","first-page":"7","article-title":"Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial - walking distance and microcirculation","volume":"53 Suppl 1","author":"De Sanctis","year":"2002","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0013|cit13","first-page":"13","article-title":"Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial","volume":"53 Suppl 1","author":"De Sanctis","year":"2002","journal-title":"Angiology"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/000331978303400105","article-title":"Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication","volume":"34","author":"Di Perri","year":"1983","journal-title":"Angiology"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1185\/03007998409109556","article-title":"Does oxpentifylline ('Trental') have a place in the treatment of intermittent claudication?","volume":"9","author":"Donaldson","year":"1984","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0016|cit16","unstructured":"Donaldson DR Kester RC Russell CW Wiggins PA Hall TJ Does oxpentifylline (Trental) have a place in the treatment of intermittent claudication? Clinical Hemorheology 1981 1 5-6 469"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/000331979204300205","article-title":"Does pentoxifylline prolong the walking distance in exercised claudicants? A placebo-controlled double-blind trial","volume":"43","author":"Ernst","year":"1992","journal-title":"Angiology"},{"issue":"4","key":"10.1002\/14651858.CD005262.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1445-5994.1985.tb02759.x","article-title":"Intermittent claudication: a double-blind crossover trial of pentoxifylline","volume":"15","author":"Gallus","year":"1985","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0019|cit19","unstructured":"Hepp W Von Bary S Corovic D Diehm C Muhe E Rudofsky G Clinical comparison of the effect of I.U. prostaglandin E1 and I.U. pentoxifylline in patients with arterial occlusive disease VASA 1992 21 4 447 Abstract No. 6.3"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0020|cit20","unstructured":"Hepp W Von Bary S Corovic D Diehm C Muhe E Rudofsky G Intravenous prostaglandin E1 versus pentoxifylline: a randomized controlled study in patients with intermittent claudication International Angiology 1995 14 Suppl 1 280"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0021|cit21","first-page":"59","article-title":"Therapeutic effectiveness of PGE1 intravenous administered comparising with pentoxifylline on intermittent claudication","volume":"14","author":"Hepp","year":"1992","journal-title":"ANGIO"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0022|cit22","first-page":"348","article-title":"Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease","volume":"33","author":"Hepp","year":"1991","journal-title":"VASA. Supplementum"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0023|cit23","first-page":"357","article-title":"Intermittent claudication. Increase in walking distance and improvement of hemorheologic parameters by pentoxifylline (Trental 400)","volume":"130","author":"Kiesewetter","year":"1988","journal-title":"MMW, Munchener Medizinische Wochenschrift"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0021-9150(01)00457-9","article-title":"Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6","volume":"158","author":"Lee","year":"2001","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1002\/14651858.CD005262.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/CS20000281","article-title":"Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication","volume":"101","author":"Lee","year":"2001","journal-title":"Clinical Science"},{"issue":"6","key":"10.1002\/14651858.CD005262.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/01.CIR.80.6.1549","article-title":"Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group","volume":"80","author":"Lindgarde","year":"1989","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD005262.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/000331978403500605","article-title":"Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication","volume":"35","author":"Perhoniemi","year":"1984","journal-title":"Angiology"},{"issue":"8","key":"10.1002\/14651858.CD005262.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/j.1552-4604.1987.tb03072.x","article-title":"Another look at the pentoxifylline efficacy data for intermittent claudication","volume":"27","author":"Gillings","year":"1987","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-8703(82)90642-1","article-title":"Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients","volume":"104","author":"Porter","year":"1982","journal-title":"American Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD005262.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/000331978403500701","article-title":"Pentoxifylline in the treatment of intermittent claudication of the lower limbs","volume":"35","author":"Reich","year":"1984","journal-title":"Angiology"},{"issue":"9","key":"10.1002\/14651858.CD005262.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/000331978703800901","article-title":"Effects of pentoxifylline on severe intermittent claudication","volume":"38","author":"Reich","year":"1987","journal-title":"Angiology"},{"issue":"6","key":"10.1002\/14651858.CD005262.pub4-BIB0032|cit32","first-page":"966","article-title":"Pharmacologic treatment of intermittent claudication","volume":"92","author":"Porter","year":"1982","journal-title":"Surgery"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0033|cit33","unstructured":"Prostaglandin E1 in outpatients with intermittent claudication clinicaltrials.gov\/ct2\/show\/NCT01263925"},{"issue":"Suppl 82","key":"10.1002\/14651858.CD005262.pub4-BIB0034|cit34","first-page":"78","article-title":"Intravenous alprostadil treatment compared to oral pentoxifylline treatment in outpatients with intermittent claudication: results of a clinical study","volume":"41","author":"Schellong","year":"2012","journal-title":"VASA"},{"issue":"5","key":"10.1002\/14651858.CD005262.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1024\/0301-1526\/a000639","article-title":"Intravenous alprostadil treatment compared to oral pentoxifylline treatment in outpatients with intermittent claudication: results of a randomised clinical trial","volume":"46","author":"Schellong","year":"2017","journal-title":"VASA"},{"issue":"32","key":"10.1002\/14651858.CD005262.pub4-BIB0036|cit36","first-page":"1244","article-title":"Treatment of arterial diseases with Trental 400. Results of a double-blind study","volume":"29","author":"Volker","year":"1978","journal-title":"Die Medizinische Welt"},{"issue":"3","key":"10.1002\/14651858.CD005262.pub4-BIB0037|cit37","first-page":"157","article-title":"Bencyclane - a new aspect of the mechanism of action in patients with peripheral arterial occlusive disease. Open-label, prospective, randomized trial","volume":"11","author":"Bieron","year":"2005","journal-title":"Acta Angiologica"},{"issue":"6","key":"10.1002\/14651858.CD005262.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF00314976","article-title":"Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study","volume":"41","author":"Ciuffetti","year":"1991","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9610(99)00147-6","article-title":"The effect of withdrawal of drugs treating intermittent claudication","volume":"178","author":"Dawson","year":"1999","journal-title":"American Journal of Surgery"},{"issue":"4 part 1","key":"10.1002\/14651858.CD005262.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0003319789040004010","article-title":"Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group","volume":"40","author":"Dettori","year":"1989","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0041|cit41","unstructured":"Ehrly AM Saeger-Lorenz K Effect of pentoxifylline on the muscle tissue oxygen pressure of claudicants after pedoergometric exercise Angiology 1986 37 5 398"},{"issue":"2 part 1","key":"10.1002\/14651858.CD005262.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/000331978703800201","article-title":"Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise","volume":"38","author":"Ehrly","year":"1987","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0043|cit43","first-page":"64","article-title":"Pentoxifylline treatment of patients with peripheral obstructive vascular disease","volume":"12","author":"Farkas","year":"1993","journal-title":"International Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00005344-199500252-00021","article-title":"Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion","volume":"25 Suppl 2","author":"Fossat","year":"1995","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"Suppl 97","key":"10.1002\/14651858.CD005262.pub4-BIB0045|cit45","first-page":"29","article-title":"Superior therapeutic effect of intermittent vasodilator infusion therapy on walking distance among patients with peripheral arterial disease and intermittent claudication","volume":"46","author":"Geppert","year":"2017","journal-title":"VASA"},{"issue":"6","key":"10.1002\/14651858.CD005262.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1185\/030079905X41471","article-title":"Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK","volume":"21","author":"Guest","year":"2005","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02043461","article-title":"Clinical efficacy of IV prostaglandin E1 and IV pentoxifylline in patients with arterial occlusive disease of fontaine stage IIb: a multicenter, randomized comparative study","volume":"5","author":"Hepp","year":"1996","journal-title":"International Journal of Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0048|cit48","first-page":"31","article-title":"Results of a multicenter randomised double blind study. Pentoxyifylline versus placebo for 6 months on lower limb artertiopathies","volume":"7","author":"Horowitz","year":"1982","journal-title":"Actualities D'Angiologie"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0049|cit49","first-page":"27","article-title":"Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial","volume":"53 Suppl 1","author":"Incandela","year":"2002","journal-title":"Angiology"},{"issue":"43","key":"10.1002\/14651858.CD005262.pub4-BIB0050|cit50","first-page":"1399","article-title":"Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400","volume":"118","author":"Kellner","year":"1976","journal-title":"MMW, Munchener Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0051|cit51","unstructured":"Luk'Janov Y Hemorheologic and hemodynamic changes after treatments with PGE versus pentoxifylline (PF) in patients with peripheral arterial disease (PAD) International Angiology 1995 14 Suppl 1 372"},{"issue":"3","key":"10.1002\/14651858.CD005262.pub4-BIB0052|cit52","first-page":"311","article-title":"Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease","volume":"51","author":"Milio","year":"2003","journal-title":"Minerva Cardioangiologica"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/187152906777441812","article-title":"The effects of prostaglandin E-1 in patients with intermittent claudication","volume":"6","author":"Milio","year":"2006","journal-title":"Cardiovascular & Hematological Disorders Drug Targets"},{"issue":"3","key":"10.1002\/14651858.CD005262.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/000331979704800308","article-title":"Effects of indobufen and pentoxifylline on walking capacity and hemostasis in patients with intermittent claudication: results of six months treatment","volume":"48","author":"Panchenko","year":"1997","journal-title":"Angiology"},{"issue":"4","key":"10.1002\/14651858.CD005262.pub4-BIB0055|cit55","first-page":"596","article-title":"Comparative evaluation of buflomedil and pentoxifylline in patients with peripheral arterial occlusive disease","volume":"37","author":"Pignoli","year":"1985","journal-title":"Current Therapeutic Research"},{"issue":"9","key":"10.1002\/14651858.CD005262.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/000331978503600907","article-title":"Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis","volume":"36","author":"Poggesi","year":"1985","journal-title":"Angiology"},{"issue":"6","key":"10.1002\/14651858.CD005262.pub4-BIB0057|cit57","first-page":"185","article-title":"The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline - a pilot study","volume":"46","author":"Regenthal","year":"1991","journal-title":"Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete"},{"issue":"828","key":"10.1002\/14651858.CD005262.pub4-BIB0058|cit58","first-page":"445","article-title":"A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects","volume":"100","author":"Reilly","year":"1987","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0059|cit59","unstructured":"Rodin SM Pletal (cilostazol) tablets Center for Drug Evaluation and Research. Application number: NDA 20-863, 1998 Study 21-96-202 27 40"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0060|cit60","unstructured":"Rodin SM Pletal (cilostazol) tablets Center for Drug Evaluation and Research. Application number: NDA 20-863 Otsuka America, 1998 Study 21-94-301 58 72"},{"issue":"7","key":"10.1002\/14651858.CD005262.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/000331978403500702","article-title":"Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration","volume":"35","author":"Roekaerts","year":"1984","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0062|cit62","first-page":"375","article-title":"Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental - results of a multicenter double-blind study","volume":"20","author":"Rudofsky","year":"1987","journal-title":"VASA. Supplementum"},{"issue":"39","key":"10.1002\/14651858.CD005262.pub4-BIB0063|cit63","first-page":"1136","article-title":"Intravenous pentoxifylline treatment in chronic peripheral arterial disease","volume":"39","author":"Rudofsky","year":"1988","journal-title":"Die Medizinische Welt"},{"issue":"7","key":"10.1002\/14651858.CD005262.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/000331978904000706","article-title":"Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline","volume":"40","author":"Rudofsky","year":"1989","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0065|cit65","first-page":"350","article-title":"Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training","volume":"33","author":"Scheffler","year":"1991","journal-title":"VASA. Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.CIR.90.2.818","article-title":"Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training","volume":"90","author":"Scheffler","year":"1994","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD005262.pub4-BIB0067|cit67","first-page":"172","article-title":"Double-blind trial of pentoxifylline in diabetics with peripheral vascular disorders","volume":"1","author":"Schubotz","year":"1976","journal-title":"Pharmatherapeutica"},{"issue":"10","key":"10.1002\/14651858.CD005262.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1185\/03007999709113331","article-title":"Controlled clinical trial on the efficacy and safety of oral sulodexide in patients with peripheral occlusive arterial disease","volume":"13","author":"Shustov","year":"1997","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12055-009-0042-8","article-title":"Effects of cilostazole and pentoxifylline on claudication distance and lipid profile in patients with occlusive peripheral arterial disease: a comparative trial","volume":"25","author":"Singh","year":"2009","journal-title":"Indian Journal of Thoracic Cardiovascular Surgery"},{"issue":"47","key":"10.1002\/14651858.CD005262.pub4-BIB0070|cit70","first-page":"3649","article-title":"Intermittent claudication treated with pentoxyphylline. A controlled trial","volume":"145","author":"Skovborg","year":"1983","journal-title":"Ugeskrift for laeger"},{"issue":"7","key":"10.1002\/14651858.CD005262.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/000331978403500709","article-title":"Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs","volume":"35","author":"Strano","year":"1984","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-200222001-00001","article-title":"Propionyl-L-carnitine versus pentoxifylline: improvement in walking capacity in patients with intermittent claudication","volume":"22 Suppl 1","author":"Strano","year":"2002","journal-title":"Clinical Drug Investigation"},{"issue":"4","key":"10.1002\/14651858.CD005262.pub4-BIB0073|cit73","first-page":"266","article-title":"Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial","volume":"9","author":"Thomson","year":"1990","journal-title":"International Angiology"},{"issue":"10","key":"10.1002\/14651858.CD005262.pub4-BIB0074|cit74","first-page":"467","article-title":"Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental","volume":"31","author":"Tonak","year":"1977","journal-title":"Medizinische Monatsschrift"},{"issue":"14","key":"10.1002\/14651858.CD005262.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2008-1062342","article-title":"A therapeutic comparison between hemodilution and pentoxifylline in arterial obstructive disease. An objective assessment by quantitative Doppler sonography","volume":"117","author":"Triebe","year":"1992","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0950-821X(05)80461-X","article-title":"Pharmacological reduction of the systemically damaging effects of local ischaemia","volume":"8","author":"Tsang","year":"1994","journal-title":"European Journal of Vascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2003.08.017","article-title":"Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication","volume":"171","author":"Wang","year":"2003","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003228.pub2","article-title":"Endovascular stents for intermittent claudication","author":"Bachoo","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD005262.pub4-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003748.pub4","article-title":"Cilostazol for intermittent claudication","author":"Bedenis","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD005262.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/000331970205300503","article-title":"Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication","volume":"53","author":"Dawson","year":"2002","journal-title":"Angiology"},{"issue":"12","key":"10.1002\/14651858.CD005262.pub4-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001368.pub4","article-title":"Naftidrofuryl for intermittent claudication","author":"Backer","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005262.pub4-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000988.pub4","article-title":"Buflomedil for intermittent claudication","author":"Backer","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD005262.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/000331979404500502","article-title":"Pentoxifylline for intermittent claudication. A critical review","volume":"45","author":"Ernst","year":"1994","journal-title":"Angiology"},{"issue":"9","key":"10.1002\/14651858.CD005262.pub4-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries","volume":"39","author":"Aboyans","year":"2018","journal-title":"European Heart Journal"},{"issue":"Suppl 102","key":"10.1002\/14651858.CD005262.pub4-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1024\/0301-1526\/a000834","article-title":"European Society for Vascular Medicine (ESVM) - guideline on peripheral arterial disease","volume":"48","author":"PAD Guideline Writing Group","year":"2019","journal-title":"VASA"},{"issue":"5-6","key":"10.1002\/14651858.CD005262.pub4-BIB0086|cit86","first-page":"499","article-title":"Surgical treatment of peripheral circulation disorders","volume":"21","author":"Fontaine","year":"1954","journal-title":"Helvetica Chirurgica Acta"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000017","article-title":"Angioplasty (versus non surgical management) for intermittent claudication","author":"Fowkes","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9901","key":"10.1002\/14651858.CD005262.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD005262.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2165\/00002512-199507060-00007","article-title":"Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders","volume":"7","author":"Frampton","year":"1995","journal-title":"Drugs & Aging"},{"issue":"8","key":"10.1002\/14651858.CD005262.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/j.1552-4604.1987.tb03072.x","article-title":"Another look at the pentoxifylline efficacy data for intermittent claudication","volume":"27","author":"Gillings","year":"1987","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0091|cit91","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"12","key":"10.1002\/14651858.CD005262.pub4-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000990.pub4","article-title":"Exercise for intermittent claudication","author":"Lane","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/2046-4053-2-81","article-title":"Assessing and presenting summaries of evidence in Cochrane reviews","volume":"2","author":"Langendam","year":"2013","journal-title":"Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0021-9150(01)00457-9","article-title":"Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6","volume":"158","author":"Lee","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0095|cit95","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0096|cit96","doi-asserted-by":"crossref","unstructured":"Marshall IJ Noel-Storr AH Kuiper J Thomas J Wallace BC Machine learning for identifying randomized controlled trials: an evaluation and practitioner's guide Research Synthesis Methods 2018 9 4 602 14","DOI":"10.1002\/jrsm.1287"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0097|cit97","unstructured":"McDonald S Noel-Storr AH Thomas J Harnessing the efficiencies of machine learning and Cochrane Crowd to identify randomised trials for individual Cochrane reviews Global Evidence Summit; 2017 Sept 13-16; Cape Town, South Africa"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0098|cit98","unstructured":"Pentoxifylline https:\/\/medlineplus.gov\/druginfo\/meds\/a685027.html"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/028134302317282716","article-title":"Incidence and management of intermittent claudication in primary care in The Netherlands","volume":"20","author":"Meijer","year":"2002","journal-title":"Scandinavian Journal of Primary Health Care"},{"issue":"3","key":"10.1002\/14651858.CD005262.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0003319712474335","article-title":"Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease","volume":"65","author":"Meng","year":"2014","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0101|cit101","unstructured":"MICROMEDEX \u00ae Healthcare Series lrs.lendac.ie\/m&p.html"},{"issue":"5","key":"10.1002\/14651858.CD005262.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2165\/00003495-200059050-00003","article-title":"Pharmacological management of intermittent claudication: a meta-analysis of randomised trials","volume":"59","author":"Moher","year":"2000","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0103|cit103","unstructured":"National Institute for Health and Care Excellence (NICE) Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease www.nice.org.uk\/ guidance\/TA223\/chapter\/2-Clinical-need-and-practice"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0104|cit104","unstructured":"National Institute for Health and Care Excellence (NICE) Lower limb peripheral arterial disease: diagnosis and management www.nice.org.uk\/Guidance\/CG147"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0105|cit105","unstructured":"Noel-Storr AH the Project Transform team Cochrane Crowd: new ways of working together to produce health evidence Evidence Live 2018; 2018 Jun 18-20; Oxford (UK)"},{"issue":"7","key":"10.1002\/14651858.CD005262.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/000331978403500701","article-title":"Pentoxifylline in the treatment of intermittent claudication of the lower limbs","volume":"35","author":"Reich","year":"1984","journal-title":"Angiology"},{"issue":"4","key":"10.1002\/14651858.CD005262.pub4-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000986.pub3","article-title":"Prostanoids for intermittent claudication","author":"Robertson","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0108|cit108","unstructured":"Pentoxifylline medicines.org.uk\/emc\/medicine\/338\/SPC\/Trental+400\/#PHARMACEUTICAL_PARTS"},{"issue":"5","key":"10.1002\/14651858.CD005262.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1024\/0301-1526\/a000639","article-title":"Intravenous alprostadil treatment compared to oral pentoxifylline treatment in outpatients with intermittent claudication: results of a randomised clinical trial","volume":"46","author":"Schellong","year":"2017","journal-title":"VASA"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0110|cit110","doi-asserted-by":"crossref","unstructured":"Squires H Simpson E Meng Y Harnan S Stevens J Wong R Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for intermittent claudication in people with peripheral arterial disease Technology Assessment Report commissioned by the NIHR HTA Programme on behalf of the National Institute for Health and Clinical Excellence 2010","DOI":"10.3310\/hta15400"},{"issue":"40","key":"10.1002\/14651858.CD005262.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15400","article-title":"A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease","volume":"15","author":"Squires","year":"2011","journal-title":"Health Technology Assessment"},{"issue":"12","key":"10.1002\/14651858.CD005262.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/bjs.8895","article-title":"Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication","volume":"99","author":"Stevens","year":"2012","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","article-title":"ESC Guidelines on the diagnosis and treatment of peripheral artery diseases","volume":"32","author":"Tendera","year":"2011","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD005262.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jclinepi.2017.08.011","article-title":"Living systematic review network. Living systematic reviews: 2. Combining human and machine effort","volume":"91","author":"Thomas","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD005262.pub4-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001272","article-title":"Antiplatelet agents for intermittent claudication","author":"Wong","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005262.pub4-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005262","article-title":"Pentoxifylline for intermittent claudication","author":"Salhiyyah","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005262.pub4-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005262.pub2","article-title":"Pentoxifylline for intermittent claudication","author":"Salhiyyah","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD005262.pub4-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005262.pub3","article-title":"Pentoxifylline for intermittent claudication","author":"Salhiyyah","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T08:20:46Z","timestamp":1674980446000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005262.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":118,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005262.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]}}}